Atherosclerotic Disease
Researchers have developed a polygenic risk score to analyze the link between dysfunctional endothelial and CAD.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
The FDA recently announced a first time proposed rule which would require the tobacco industry to lower nicotine levels.
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
A study found a comparable reduction in LDL-C with statins and bempedoic acid in patients with and without ASCVD.
Higher lipoprotein(a) levels are associated with an increased progression of coronary plaque burden.
Advertisement
Expert Interviews on Atherosclerosis
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.